Hospital
Alecto Healthcare Services Fairmont LLC
Alecto Healthcare Services Fairmont LLC was paid $11.68M by Medicaid between Jan 2018 and Mar 2020, across 133 billing codes. Its largest line is G0378, Hospital observation service, per hour — 8.3% of everything it billed.
33Billing provider infoALECTO HEALTHCARE SERVICES FAIRMONT LLC
FAIRMONT, WV 26554
FAIRMONT, WV 26554
33aNPI1649688037assigned 07/29/2014
33bProvider typeGeneral Acute Care Hospital
28Total paid$11.68M
24GClaims110,801
24DCodes billed133
24AFirst – last monthJan 2018 – Mar 2020
Compared with peers
Next to other General Acute Care Hospital providers in West Virginia
Rank by total paid#17 of 26
Median peer was paid$18.33M
This provider vs. median0.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 67,674 | $8.06M | |
| 2019 | 32,210 | $2.29M | |
| 2020 | 10,917 | $1.33M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| G0378 | Hospital observation service, per hour | 8.3% | 2,685 | 840 | $971K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 6.0% | 5,374 | 4,781 | $704K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 5.9% | 4,172 | 3,666 | $686K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 4.8% | 1,888 | 1,422 | $562K |
| 80053 | Comprehensive metabolic panel | 4.1% | 6,049 | 4,662 | $478K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 4.0% | 7,303 | 5,456 | $470K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 3.3% | 546 | 454 | $380K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.7% | 3,155 | 2,443 | $321K |
| 84484 | 2.6% | 2,905 | 1,901 | $309K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.2% | 3,495 | 2,746 | $259K |
| 36415 | Collection of venous blood by venipuncture | 2.2% | 3,603 | 2,318 | $258K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.1% | 1,259 | 1,119 | $246K |
121 more codes
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.0% | 2,535 | $231K |
| 93017 | 1.9% | 374 | $223K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.9% | 2,036 | $220K |
| 83735 | 1.9% | 2,912 | $218K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 1.7% | 248 | $200K |
| 71045 | Radiologic examination, chest; single view | 1.7% | 2,009 | $197K |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.6% | 2,248 | $190K |
| 82550 | 1.6% | 1,563 | $190K | |
| 81025 | 1.5% | 1,632 | $172K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.5% | 1,109 | $171K |
| 71046 | Radiologic examination, chest; 2 views | 1.3% | 1,752 | $151K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.3% | 1,505 | $150K |
| 81001 | 1.2% | 2,388 | $139K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1.2% | 1,970 | $136K |
| 84443 | Thyroid stimulating hormone (TSH) | 1.0% | 1,391 | $121K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,644 | $114K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 2,300 | $111K |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | <1% | 225 | $111K |
| 85730 | <1% | 1,350 | $108K | |
| 83690 | <1% | 1,618 | $104K | |
| 85610 | <1% | 1,557 | $102K | |
| 82553 | <1% | 834 | $97K | |
| 83880 | <1% | 797 | $96K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 1,318 | $94K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 869 | $91K |
| 85027 | <1% | 1,153 | $90K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 128 | $86K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 379 | $85K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 313 | $79K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,091 | $78K |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 132 | $70K |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 492 | $70K |
| 82150 | <1% | 1,095 | $68K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 312 | $66K |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 238 | $63K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 481 | $60K |
| 87040 | <1% | 772 | $57K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 322 | $54K |
| 87070 | <1% | 867 | $54K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 1,557 | $54K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 548 | $53K |
| 81003 | <1% | 624 | $52K | |
| 83605 | <1% | 767 | $51K | |
| 80061 | Lipid panel | <1% | 431 | $51K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 424 | $47K |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 510 | $44K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 925 | $41K |
| 87077 | <1% | 703 | $40K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 219 | $38K |
| 85379 | <1% | 439 | $37K | |
| 73630 | <1% | 299 | $37K | |
| 87186 | <1% | 667 | $33K | |
| 82248 | <1% | 653 | $32K | |
| 73130 | <1% | 231 | $32K | |
| 73610 | <1% | 254 | $32K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 300 | $31K |
| J3490 | Unclassified drugs | <1% | 245 | $31K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 510 | $29K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 165 | $26K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 658 | $26K |
| 73564 | <1% | 176 | $26K | |
| 82746 | <1% | 381 | $25K | |
| 73030 | <1% | 198 | $24K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 55 | $24K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 338 | $20K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 249 | $20K |
| 84439 | <1% | 326 | $19K | |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 106 | $18K |
| 85652 | <1% | 193 | $17K | |
| 97014 | <1% | 389 | $16K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 282 | $14K |
| 82607 | <1% | 210 | $14K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 122 | $13K |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 38 | $13K |
| 70486 | <1% | 57 | $13K | |
| 87205 | <1% | 225 | $13K | |
| 93971 | <1% | 29 | $13K | |
| 84436 | <1% | 195 | $12K | |
| 73110 | <1% | 84 | $12K | |
| 88342 | <1% | 31 | $11K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 152 | $11K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 151 | $11K |
| 84702 | <1% | 87 | $10K | |
| 87420 | <1% | 136 | $10K | |
| 71250 | <1% | 33 | $10K | |
| 97162 | <1% | 41 | $10K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 51 | $9K |
| 97161 | <1% | 156 | $8K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 73 | $8K |
| 74022 | <1% | 68 | $5K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 31 | $5K |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | <1% | 64 | $5K |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | <1% | 61 | $5K |
| 82803 | <1% | 18 | $5K | |
| 36600 | <1% | 18 | $5K | |
| 86901 | <1% | 82 | $5K | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 70 | $4K |
| 86850 | <1% | 78 | $4K | |
| J2780 | Injection, ranitidine hydrochloride, 25 mg | <1% | 37 | $3K |
| 96376 | <1% | 80 | $3K | |
| 83540 | <1% | 49 | $3K | |
| 82728 | <1% | 45 | $3K | |
| 73080 | <1% | 16 | $3K | |
| 86900 | <1% | 74 | $2K | |
| 83550 | <1% | 31 | $2K | |
| 73502 | <1% | 12 | $2K | |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | <1% | 25 | $2K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 20 | $1K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 17 | $1K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 17 | $1K |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | <1% | 56 | $1K |
| 74019 | <1% | 28 | $1K | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | <1% | 27 | $1K |
| 97166 | <1% | 27 | $883.83 | |
| V2630 | Anterior chamber intraocular lens | <1% | 14 | $839.09 |
| 87430 | <1% | 12 | $700.86 | |
| 82009 | <1% | 13 | $525.90 | |
| 73090 | <1% | 16 | $469.10 | |
| 86140 | <1% | 31 | $376.21 | |
| A9270 | Non-covered item or service | <1% | 5,564 | $251.55 |
| 73590 | <1% | 14 | $163.25 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSARRAO, MICHAEL (EXECUTIVE VICE-PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Prime Healthcare Services Roxborough LLC | Philadelphia, PA | $8.76M |
| Alecto Healthcare Services Wheeling LLC | Wheeling, WV | $6.00M |
| Alecto Healthcare Services Martins Ferry LLC | Martins Ferry, OH | $963K |
| Alecto Healthcare Services Wheeling LLC | Wheeling, WV | $956K |
| Sherman MD Provider INC | Sherman, TX | $849K |
| FRMC Physicians, INC. | Fairmont, WV | $816K |
| Alecto Healthcare Services Martins Ferry LLC | Martins Ferry, OH | $194K |
| Prime Healthcare Services Pampa LLC | Pampa, TX | $14K |
| Prime Healthcare Services Pampa LLC | Pampa, TX | $7K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.